Barry F. Cohen
Chief Executive Officer
Mr. Cohen founded the Company and has served as its Chief Executive Officer and a Director since February 4, 2015.
Between 2006 and 2008, Mr. Cohen was a private investor and founded AVRA Surgical, Inc., a medical technology company. From approximately 1979 to 1983, he served as Director of Synalloy Corp., a manufacturer of pipe, piping systems and specialty chemicals after which he was appointed to serve as President from 1984 to 1985.
Mr. Cohen also served as Chairman of the Executive Board of Wolverine Technologies, Inc., a NYSE listed company from 1979 to 1983 and President of Barry F. Cohen & Co, an NASD member from 1983 to 1999. Mr Cohen has over 50 years of experience in managing private and public industrial companies, and 47 years of experience as a securities executive.
Nikhil Lalit Shah, DO, MPH
Chief Strategy Officer
Dr. Shah is one of the top global leaders in robotic cases and serves as the AVRA Medical Chief Strategy Officer.
He is currently the head of Minimal Access & Robotic Surgery at Piedmont Healthcare in Atlanta, GA. He has previously served as the Medical Director of The Jenkins Clinic in Atlanta and is also an Associate Professor (adjunct) at the Georgia Institute of Technology in the College of Computing – Robotics & Intelligent Machines. Prior positions also include the Section Chief of Urology, Department of Surgery, Saint Joseph’s Hospital of Atlanta, and the Director of Robotic Surgery, Saint Joseph’s Hospital of Atlanta.
Dr. Ray Powers
Chief Operating Officer
Dr. Powers was an executive within the Bell System for 30 years prior to moving on to C-level positions…
in the technology sector in both private and public companies. He has served as Director of Standards for the Project Management Institute and on their Board of Directors. He has been a professor and an academic department chair in higher education at the Forbes School of Business, holds an MBA in Technology Management, and a Doctoral degree in Leadership from the University of Phoenix.
Farhan Taghizadeh, MD
Chief Medical Officer
Dr. Taghizadeh, also known as “Dr. T” is a Board-certified ENT, Plastic & Reconstructive surgeon.
He completed his ENT training at the University of Rochester, and thereafter journeyed to Switzerland for a fellowship specializing in facial cosmetic surgery. His intensive specialized training only deepened his understanding of the complexity of the facial structure and fostered an in-depth understanding of the head and neck. Honing his diverse and extensive technical skills, he has become a recognized global authority delivering reproducible outcomes only possible with someone with skill and expertise.
Over the course of his extensive ENT and cosmetic surgery training, he has performed more than 3,500 facelifts. Offering the latest procedures and techniques available in the medical cosmetic industry, Dr. T is constantly interfacing with the world’s most prominent cosmetic device and product manufacturers to stay on top of the newest devices and treatments on the market and find new, innovative ways to deliver results with unsurpassed satisfaction by his patients, their friends and their loved ones.
Ms. Bergman-Fong has been advising and supporting the development of a number of start-up businesses…
and small businesses in New York and across the globe for over a decade. She previously was a finance partner in the law firm of Mayer Brown for 10 years. From 1984 through 1991, Ms. Bergman-Fong was a finance associate at Cravath, Swaine & Moore in the M&A to Structured Finance Area. She attended Brown University and was a Harlan Fiske Stone Scholar at Columbia Law School, where she graduated with honors. She is a member of the New York Bar.
Board of Directors
Barry F. Cohen
Chairman of the Board
Mr. Cohen founded the Company and has served as its Chief Executive Officer and a Director since February 4, 2015.
Between 2006 and 2008, Mr. Cohen was a private investor and founded AVRA Surgical, Inc., a medical technology company. From approximately 1979 to 1983 he served as Director of Synalloy Corp., a manufacturer of pipe, piping systems and specialty chemicals after which he was appointed to serve as President from 1984 to 1985.
Mr. Cohen also served as Chairman of the Executive Board of Wolverine Technologies, Inc., as NYSE listed company from 1979 to 1983 and President of Barry F. Cohen & co, an NASD member from 1983 to 1999. Mr Cohen has over 50 years’ experience in managing private and public industrial companies, and 47 years of experience as a securities executive.
A. Christian Schauer
Since 2003, Mr. Schauer has also served as Chairman, President, and CEO of PharmOptima LLC…
a pre-clinical contract research company based in Portage, Michigan. From 1999 until it was acquired by Eimo of Finland in 2001, Mr. Schauer served as Chief Executive Officer of Triple S. Plastics. From 25 years prior, he served in various senior management positions with Clausing Corporation, including Chairman and Chief Executive Officer from 1984 until 1999.
Before joining Clausing Corporation, Mr. Schauer was with Ernst & Ernst (now Ernst & Young) for approximately a decade. A certified public accountant, he holds a B.B.A. in accounting from Western Michigan University. Mr. Schauer has served as an executive and non-executive director for several companies, including First of America Bank, Durametallic Corporation, Triple S Plastics, Harter Corporation, the 600 Group Plc. (London) and Z Seven Fund. Mr. Schauer currently serves as a non-executive director for Griffith Foods, Inc., and as a Trustee of the Boards at Kalamazoo Valley Community College and Hope Network.
Peter Carnegie is a leader in developing successful robotic surgery programs in storied institutions like the Cleveland Clinic…
the University of Alabama, Birmingham, the University of Pittsburgh Medical Center and West Virginia University Hospitals. He also is an expert in developing robotic and medical device training programs, surgeon training programs, nurse training programs, and clinical and sales training programs. Mr. Carnegie has been the CEO of Minimally Invasive Solutions consulting (MIS), a robotic surgery consulting firm since 2011. Prior to becoming the CEO of MIS, he was its Chief Operating Officer. Before, MIS, he worked at Intuitive Surgical, Inc. as U.S. Program Development Manager for Cardiothoracic, Head & Neck Surgery. Prior to working for Intuitive, he was at Ethicon Endo-Surgery of Johnson & Johnson.
He has headed programs in robotic training, including the Symposium on Science, Technology and Advanced Robotics in partnership with the Links Inc. Professional Opportunities Program for Students of the University of Central Florida, the University of South Florida, and Valencia College. He is a decorated war veteran and recipient of the Douglas McArthur Leadership Award, and holds a BS degree in engineering from West Point.
Medical Advisory Board
Vipul Patel, MD
Dr. Vipul Patel is Medical Director of the Global Robotics Institute at Florida Hospital.
Founder of the Society of Robotic Surgery, Dr. Patel has personally performed the most robotic surgeries in the world, 10,000+ robotic prostatectomies. He is also a Professor at the University of Central Florida College of Medicine.
Juan Jose Badimon, PhD
Dr. Juan Jose Badimon is a Professor of Medicine and Director of the Atherothrombosis Research Unit…
at the Cardiovascular Institute, Mount Sinai School of Medicine, New York. He graduated from the University of Barcelona in 1982. His academic appointments include Mayo Clinic, Massachusetts General Hospital, Harvard University, and Mount Sinai School of Medicine in New York.
His major research interests are focused on pathogenesis and treatment of atherothrombosis and cardiovascular diseases. Dr. Badimon has published more than 370 peer-reviewed articles in atherothrombosis, imaging, and cardiovascular diseases. He serves as a reviewer for 10 of the top journals in cardiovascular diseases.
Yuman Fong, MD
Dr. Yuman Fong is an internationally recognized expert in cancer and is a sought-after consultant…
on a wide range of medical robotic research. Dr. Fong is currently Chair of the Department of Surgery for City of Hope and was at the renowned Memorial Sloan-Kettering Cancer Center in New York City for the prior two decades. Dr. Fong is also both author and innovator: he has developed many new surgical techniques and instruments and written and edited hundreds of scholarly articles, as well as nearly a dozen textbooks.
Hiep Nguyen, MD
Dr. Hiep Nguyen is a world-renowned Pediatric Urologist specializing in robotic…
minimally invasive surgery, ureter pelvic junction (UPJ) obstruction, vesicoureteral reflux and reconstructive surgery. Dr. Nguyen was Director of the Robotic Surgery, Research, and Training Center at Children’s Hospital Boston; the Rose Zimmerman Mandell Chair in Innovative Urological Technology; and Associate Professor (Surgery) at Harvard Medical School and Boston Children’s Hospital. He is currently at the Carson Children’s Medical Center in Mesa, Arizona.
Heywood Y. Epstein, MD
Dr. Heywood Y. Epstein was Chief Resident in Radiation Therapy at Montefiore Hospital…
in the Bronx NY as well as Assistant Professor of Radiology at Columbia P&S, NYU, Mt. Sinai in NY, and Stony Brook, NY. While in the US Public Health Service, he was Director of Staten Island Radiology Residency Program, Director of their Radiology Technologist Training Program, and USPHS radiation safety officer for the Northeast United States. Dr. Epstein helped establish NYU’s first ultrasound section in their Radiology Department and has coauthored 25 articles published in juried journals. Dr. Epstein has performed approximately 10,000 angiograms and interventional radiographic procedures, in addition to another 10,000 breast biopsies guided by ultrasound, and stereotactically.
Jochen Binder, Priv. Doz. Dr. med.
Dr. Jochen Binder was the first physician worldwide to perform Da Vinci prostate surgery in 2000…
and in 2005, Dr. Binder received Recognition of the First da Vinci Prostatectomy, European Robotic Urology Symposium ERUS, Geneva. His live surgeries have been televised via global viewing, he is a published author and the subject of many articles and reviews.
He was Chief of the Urology Department at Universitatsklinikum Frankfurt am Main, Klinik fur Urologie und Kinderurologie and Kantonsspital Frauenfeld, Switzerland. He is currently with Klinik Seeschau Kreuzlingen, Klinik Hirslanden Zurich, Spital Mannedorf and Klinik Uroviva Bulach.
Dr. Binder is a former rugby player and the father of four daughters. He resides in Switzerland.
Scientific Advisory Board
Andrew M. Economos, PhD
Andrew M. Economos, Ph.D., earned his MS in Mathematics at UF, and moved to…
Los Angeles to work in the Aerospace computing industry. He earned his Ph.D. in Mathematical Statistics at UCLA, and after some years moved to Princeton to work in the RCA’s Sarnoff Labs. From there he went to RCA subsidiary company NBC in New York, where he was VP of Management Information Services, managing the immense computing needs of NBC.
From there he founded and led a highly successful broadcast software company, which he sold in 2005. He and his wife, Judith, were sponsors for six years of three high school’s robotics teams in Westchester. He has served on The New York Botanical Garden’s Science Committee and Corporation Board, the Board of Selby Gardens in Sarasota, and the Board of the Science Committee of Westchester Community College.
Mrs. Pollak has over twenty-eight years of experience as a senior system and software engineer…
in high performance advanced image generators for visual simulation applications and mathematical algorithms validation for military and commercial aircrafts, weapons, sensors and Automated Fingerprint Identification Systems. She has worked at General Electric, Martin Marietta and Lockheed Martin. She attended Speed graduate School of Engineering at University of Louisville, KY and received her BS degree at Krannert School of Management at Purdue University West Lafayette, IN.
Fred Nazem, PhD
Mr. Nazem has been building highly disruptive, industry-leading healthcare and technology…
companies since the late 1970’s. He is best known as the turnaround specialist who led the successful reorganization of Oxford Health Plans, which was later sold to United Healthcare for more than $6 billion. A number of his start-up ventures have grown to become billion dollar enterprises and more than a dozen of them have achieved multi-billion dollar revenue status.
A scientist turned financier, Mr. Nazem holds a degree in biochemistry, a graduate degree in physical chemistry, an MBA in finance, and has done doctoral work in quantum physics.
NYU Medical School, and completed a fellowship in immunology at Memorial Sloan Kettering Cancer Center (MSKCC). Dr. Safai’s work in immunology earned him a degree of Doctor of Medical Sciences (D.Sc.) from the University of Gutenberg, Sweden. He continued his career at MSKCC where he established a dermatology program to include research, education and patient care. During his tenure, he developed programs for the management of various skin cancers, lymphoma of the skin and Kaposi’s Sarcoma.